Heart failure evidence update 2026 - PubMed
7 hours ago
- #Heart Failure
- #Medical Devices
- #Pharmacotherapy
- Major developments in heart failure (HF) treatment across the entire ejection fraction (EF) spectrum.
- Emergence of non-steroidal mineralocorticoid receptor antagonists and incretin-based therapies for HF with mildly reduced and preserved EF.
- Validation of rapid guideline-directed medical therapy optimization strategies in acute HF.
- New evidence supporting digitalis glycosides in HF patients with reduced EF.
- Advancements in device-based care, including transcatheter edge-to-edge repair for valvular heart disease.
- Potential reshaping of contemporary clinical practice based on new evidence.